Franz Zehentmayr

ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 10

Top Venues

Thoracic cancer

Cancers

Current oncology (Toronto, Ont.)

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Stana, Brane Grambozov, Josef Karner, Isabella Gollner, Christoph Gaisberger, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL CO Correlate with Radiation Dosimetry and Pneumonitis Rate. Cancers 15 (7) (2023)
Romana Wass, Maximilian Johannes Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity. Cancers 14 (13) (2022)
Markus Stana, Brane Grambozov, Christoph Gaisberger, Josef Karner, Elvis Ruznic, Johannes Berchtold, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Carbon Monoxide Diffusing Capacity (DL CO ) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Brane Grambozov, Markus Stana, Bernhard Kaiser, Josef Karner, Sabine Gerum, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC. Cancers 14 (3) (2022)
Brane Grambozov, Romana Wass, Markus Stana, Sabine Gerum, Josef Karner, Gerd Fastner, Michael Studnicka, Felix Sedlmayer, Franz Zehentmayr
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis. Thoracic cancer 12 (8) (2021)
Brane Grambozov, Evelyn Nussdorfer, Julia Kaiser, Sabine Gerum, Gerd Fastner, Markus Stana, Christoph Gaisberger, Romana Wass, Michael Studnicka, Felix Sedlmayer, Franz Zehentmayr
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis. Current oncology (Toronto, Ont.) 28 (3) (2021)
Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, Cornelia Kronberger, Brane Grambozov, Elvis Ruznic, Markus Stana, Josef Karner, Gerd Fastner, Karl Sotlar, Felix Sedlmayer, Franz Zehentmayr
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3. Breast cancer (Tokyo, Japan) (2021)
Franz Zehentmayr, Brane Grambozov, Julia Kaiser, Gerd Fastner, Felix Sedlmayer
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review. Thoracic cancer 11 (6) (2020)
Brane Grambozov, Frank Wolf, Julia Kaiser, Romana Wass, Gerd Fastner, Christoph Gaisberger, Lukas Rettenbacher, Michael Studnicka, Christian Pirich, Felix Sedlmayer, Franz Zehentmayr
Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer. Thoracic cancer 11 (2) (2019)
Franz Zehentmayr, Martin Sprenger, Lukas Rettenbacher, Romana Wass, Peter Porsch, Gerd Fastner, Christian Pirich, Michael Studnicka, Felix Sedlmayer
Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation. Thoracic cancer 10 (2) (2019)
Felix Sedlmayer, Roland Reitsamer, Christoph Fussl, Ingrid Ziegler, Franz Zehentmayr, Heinz Deutschmann, Peter Kopp, Gerd Fastner
Boost IORT in Breast Cancer: Body of Evidence. International journal of breast cancer 2014 (2014)

Franz Zehentmayr.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Franz Zehentmayr